Decision Analysis Modelling of Costs and Outcomes following Cefepime Monotherapy in Canada

Halpern, Michael T.; Brown, Ruth E.; Drolet, Martine; Sorensen, Sonja; Mandell, Lionel A.

doi:10.1155/1997/106462

Cited by 2 publications

(1 citation statement)

References 19 publications

(14 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the present example, the baseline probabilities were obtained from the literature ( Table 2). (11)(12)(13)(14)(15)(16). In the example chosen for the present paper, utilities were used as the outcome measure.…”

Section: Stages Of Mdamentioning

confidence: 99%

Medical Decision Analysis in Infectious Diseases

Allen

2000

Canadian Journal of Infectious Diseases and Medical Microbiolog

View full text Add to dashboard Cite

Medical decision analysis (MDA) has played an important role in assisting infectious disease physicians make decisions associated with varying levels of complexity. Clinicians are often uncomfortable with some aspects of MDA, particularly when utilities are used as outcome measures. However, as the present paper outlines, MDA may use other outcome variables, including costs and disease complications. In this context, this explicit, reproducible analytic framework is an important tool in the area of infectious diseases, and is frequently applied to many situations, including cost effectiveness analyses, studies involving assessment of risks versus benefits of preventive and treatment strategies, and other situations. The objective of this paper is to assist infectious diseases clinicians to understand better the role of MDA in clinical practice. In this regard, the principles of MDA are reviewed and a common clinical example is used for illustrative purposes.

show abstract

Section: Stages Of Mdamentioning

confidence: 99%

Medical Decision Analysis in Infectious Diseases

Allen

2000

Canadian Journal of Infectious Diseases and Medical Microbiolog

View full text Add to dashboard Cite

show abstract

Health and Economic Outcomes Modeling Practices: A Suggested Framework

Halpern¹,

Luce²,

Brown³

et al. 1998

Value in Health

View full text Add to dashboard Cite

In the field of outcomes research, modeling is increasingly being used to assess costs and outcomes associated with healthcare interventions. However, there is little standardization with regard to modeling practices, and the quality and usefulness of economic and health outcomes models may vary. We propose the following set of recommendations for good modeling practices to be used in both the development and review of models. These recommendations are divided into three sections: criteria to be addressed before model development or initial review; criteria used during model development or evaluation; and criteria used following model development. These recommendations also include examples regarding different modeling techniques and practices as well as a checklist (see appendix) to assess model correspondence with the recommendations. We hope that the use of good practice recommendations for modeling will not only improve the development and review of models but also lead to greater acceptance of this methodology.

show abstract

Decision Analysis Modelling of Costs and Outcomes following Cefepime Monotherapy in Canada

Abstract: Initial empiric monotherapy with cefepime for serious infectious disease conditions may result in cost savings compared with alternative parenteral agents.

Cited by 2 publications

References 19 publications

Medical Decision Analysis in Infectious Diseases

Medical Decision Analysis in Infectious Diseases

Health and Economic Outcomes Modeling Practices: A Suggested Framework

Contact Info

Product

Resources

About